Medicinal Mushrooms for the Dietary Supplement and Pharmaceutical Market
The medicinal benefits of mushrooms are well recognized to help treat illnesses and maintain health and wellness. There are well over 10,000 peer-reviewed scientific papers on the health aspects of medicinal mushrooms.
Medicinal Mushrooms are also an important raw material for manufacturing many drugs, including anti-cholesterol medications, anti-cancer drugs, antibiotics, anti-rejection drugs and most recently, the newly evolving categories of anti-viral drugs, critically needed today as the pandemic has shown the weakness in this part of our medical industry.
A core application of Ayla’s technology is the controlled, solid-state fermentation process to produce medicinal mushrooms and mushroom-derived compounds. Ayla’s Medicinal Mushroom Production Division is currently under construction and will have a capacity of 50 tons per month by Q1 2023. Ayla is expected to take over a large portion of the dietary supplement market in this sector within the next 12 months. This is primarily because Ayla’s President and CEO, Dr. John Holliday, is one of the most well-known figures today in the Medicinal Mushroom industry and known as one of the pioneers in this field, being the person that first introduced Medicinal Mushrooms to the North American market in the mid-1990s. As the sole founder and president of the global #1 Medicinal Mushroom company, Dr. John is very active and well known internationally in the Medicinal Mushroom field. Dr. John currently holds many professional positions in this sector of the mushroom industry, including:
͠ Vice President of the International Society of Medicinal Mushrooms, (ISMM)
͠ Vice President of the African Society of Edible and Medicinal Mushrooms (ASEMM),
͠ Editor for the International Journal of Medicinal Mushrooms,
͠ Editor for the Open Access Journal of Mycology & Mycological Sciences,
͠ Member of the organizing committee for the bi-annual International Medicinal Mushroom Conference (IMMC).
Dr. John has published approximately one hundred articles and book chapters on Medicinal Mushrooms, including the Cordyceps chapter in the standard reference manual for dietary supplements, the Encyclopedia of Dietary Supplements. Dr. John has several patents, both issued and pending, on various aspects of Medicinal Mushroom production technology. Dr. John brings to Ayla more than 20 years of directly leading advances in the latest production methods and quality control for medicinal mushrooms, proprietary advances unknown and unused by any competitor in this industry sector.
Join Our Team
We are looking for passionate, innovative people to join us